1. Robert Koch Institut. Gesundheit in Deutschland. Gesundheitsberichterstattung des Bundes. Berlin: RKI, Gemeinsam getragen von RKI und Destatis; 2015.
  2. Lundström E, Smits A, Terént A, Borg J. Time-course and determinants of spasticity during the first six months following first-ever stroke. J Rehabil Med. 2010 Apr;42(4):296-301.
  3. Wissel J, Manack A & Brainin M. Toward an epidemiology of poststroke spasticity. Neurology. 2013 Jan 15;80:S13-9.
  4. Kheder A, Nair KP. Spasticity: pathophysiology, evaluation and management. Pract Neurol. 2012 Oct;12(5):289-98. 
  5. Graham LA. Management of spasticity revisited. Age Ageing. 2013 Jul;42(4):435-41. 
  6. Bhimani R, Anderson L. Clinical understanding of spasticity: implications for practice. Rehabil Res Pract. 2014;2014: 279175.
  7. Potempa C, Thiem H, Rychlik R, et al. Zur Versorgungslage von Patienten mit spastischer Bewegungsstörung in Deutschland. Monit Versorgungsforschung. 2019;12:65-72.
  8. Ashford S, Turner-Stokes L, Allison R, Duke L. College of Physicians. Spasticity in adults: management using botulinum toxin. 2. Ed. National Guidelines. Royal College of Physicians; 2018.
  9. Brainin M, Norrving B, Sunnerhagen KS, et al. International PSS Disability Study Group. Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications. Int J Stroke. 2011 Feb;6(1):42-6.
  10. Duncan PW, Zorowitz R, Bates B, Choi JY, Glasberg JJ, Graham GD, Katz RC, Lamberty K, Reker D. Management of Adult Stroke Rehabilitation Care: a clinical practice guideline. Stroke. 2005 Sep;36(9):e100-43. 
  11. Glaess-Leistner S, Ri SJ, Audebert HJ, Wissel J. Early clinical predictors of post stroke spasticity. Top Stroke Rehabil. 2021 Oct;28(7):508-518.
ABBV-DE-00960-MC